share_log

UBS Maintains Buy on Applied Therapeutics, Raises Price Target to $13

UBS Maintains Buy on Applied Therapeutics, Raises Price Target to $13

瑞银维持对应用疗法的买入,将目标股价上调至13美元
Benzinga ·  03/15 08:46

UBS analyst Esther Rajavelu maintains Applied Therapeutics (NASDAQ:APLT) with a Buy and raises the price target from $12 to $13.

瑞银分析师埃丝特·拉贾维卢维持应用疗法(纳斯达克股票代码:APLT)的买入并将目标股价从12美元上调至13美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发